Literature DB >> 23140576

Early-stage non-small cell lung cancer in elderly patients: should stereotactic radiation therapy be the standard of care?

David A Palma, Suresh Senan.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23140576     DOI： 10.1016/j.ijrobp.2012.07.2353

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  10 in total

Review 1.  New techniques for assessing response after hypofractionated radiotherapy for lung cancer.

Authors:  Sarah A Mattonen; Kitty Huang; Aaron D Ward; Suresh Senan; David A Palma
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada.

Authors:  Alexander V Louie; George B Rodrigues; David A Palma; Suresh Senan
Journal:  Oncologist       Date:  2014-06-20

3.  Stereotactic body radiation therapy for a new lung cancer arising after pneumonectomy: dosimetric evaluation and pulmonary toxicity.

Authors:  Alessandro Testolin; Maria Silvia Favretto; Stefania Cora; Carlo Cavedon
Journal:  Br J Radiol       Date:  2015-08-20       Impact factor: 3.039

4.  Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes.

Authors:  Sashendra Senthi; Cornelis J A Haasbeek; Frank J Lagerwaard; Wilko F Verbakel; Patricia F de Haan; Ben J Slotman; Suresh Senan
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

5.  Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a single-center experience.

Authors:  Vanessa Figlia; Rosario Mazzola; Francesco Cuccia; Filippo Alongi; Gianluca Mortellaro; Daniela Cespuglio; Teresa Cucchiara; Giuseppina Iacoviello; Vito Valenti; Massimo Molino; Francesco Verderame; Domenica Matranga; Antonio Lo Casto; Giuseppe Ferrera
Journal:  Radiol Med       Date:  2018-02-17       Impact factor: 3.469

Review 6.  [Radiation pneumonitis after stereotactic body radiation therapy for early stage non-small cell lung cancer].

Authors:  Lu Chen; Yaqin Zhao; Feng Xu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-04

7.  Evaluating risk factors of radiation pneumonitis after stereotactic body radiation therapy in lung tumor: Meta-analysis of 9 observational studies.

Authors:  Chi Lu; Zhang Lei; Hongbin Wu; Hongda Lu
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

8.  Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancer.

Authors:  Shinya Hayashi; Hidekazu Tanaka; Yuuichi Kajiura; Yasushi Ohno; Hiroaki Hoshi
Journal:  Radiat Oncol       Date:  2014-06-16       Impact factor: 3.481

9.  On the robustness of VMAT-SABR treatment plans against isocentre positioning uncertainties.

Authors:  Joep Stroom; Sandra Vieira; Dalila Mateus; Carlo Greco; Antonella Fogliata; Giorgia Nicolini; Alessandro Clivio; Eugenio Vanetti; Luca Cozzi
Journal:  Radiat Oncol       Date:  2014-09-05       Impact factor: 3.481

Review 10.  Racial and socioeconomic disparities in the use of stereotactic body radiotherapy for treating non-small cell lung cancer: a narrative review.

Authors:  Yue Lin; Kimberley S Mak
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.